1. Multidisciplinary rehabilitation treatment is not effective for myalgic encephalomyelitis/chronic fatigue syndrome: A review of the FatiGo trial
- Author
-
Alexandra Vink-Niese and Mark Vink
- Subjects
medicine.medical_specialty ,Encephalomyelitis ,lcsh:BF1-990 ,chronic fatigue syndrome ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Chronic fatigue syndrome ,Medicine ,030212 general & internal medicine ,multidisciplinary rehabilitation treatment ,business.industry ,Significant difference ,Critical Review ,cognitive behavioural therapy ,medicine.disease ,Cognitive behaviour therapy ,myalgic encephalomyelitis ,Psychiatry and Mental health ,Clinical Psychology ,lcsh:Psychology ,FatiGo ,Physical therapy ,business ,030217 neurology & neurosurgery ,Multidisciplinary rehabilitation - Abstract
The FatiGo trial concluded that multidisciplinary rehabilitation treatment is more effective for chronic fatigue syndrome/myalgic encephalomyelitis in the long term than cognitive behaviour therapy and that multidisciplinary rehabilitation treatment is more cost-effective for fatigue and cognitive behaviour therapy for quality of life. However, FatiGo suffered from a number of serious methodological flaws. Moreover, it ignored the results of the activity metre, its only objective outcome. This jeopardizes the validity of FatiGo. Its analysis shows that there was no statistically significant difference between multidisciplinary rehabilitation treatment and cognitive behaviour therapy and neither are (cost-)effective. FatiGo’s claims of efficacy of multidisciplinary rehabilitation treatment and cognitive behaviour therapy for chronic fatigue syndrome/myalgic encephalomyelitis are misleading and not justified by their results.
- Published
- 2018